Annual Current Liabilities
$4.84 M
-$1.91 M-28.32%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual total current liabilities is $4.84 million, with the most recent change of -$1.91 million (-28.32%) on December 31, 2023.
- During the last 3 years, CMMB annual current liabilities has risen by +$3.52 million (+267.63%).
- CMMB annual current liabilities is now -28.32% below its all-time high of $6.75 million, reached on December 31, 2022.
Performance
CMMB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.35 M
+$41.00 K+0.95%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly total current liabilities is $4.35 million, with the most recent change of +$41.00 thousand (+0.95%) on September 1, 2024.
- Over the past year, CMMB quarterly current liabilities has increased by +$41.00 thousand (+0.95%).
- CMMB quarterly current liabilities is now -37.84% below its all-time high of $7.00 million, reached on March 31, 2023.
Performance
CMMB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CMMB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.3% | +0.9% |
| 3 y3 years | +267.6% | +0.9% |
| 5 y5 years | +267.6% | +0.9% |
CMMB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.3% | +82.6% | -37.8% | +64.1% |
| 5 y | 5-year | -28.3% | +267.6% | -37.8% | +230.5% |
| alltime | all time | -28.3% | +267.6% | -37.8% | +230.5% |
Chemomab Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.35 M(+1.0%) |
| Jun 2024 | - | $4.31 M(-2.0%) |
| Mar 2024 | - | $4.40 M(-9.1%) |
| Dec 2023 | $4.84 M(-28.3%) | $4.84 M(-29.1%) |
| Jun 2023 | - | $6.83 M(-2.5%) |
| Mar 2023 | - | $7.00 M(+3.7%) |
| Dec 2022 | $6.75 M | $6.75 M(+23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.48 M(+24.6%) |
| Jun 2022 | - | $4.39 M(+24.9%) |
| Mar 2022 | - | $3.52 M(+32.7%) |
| Dec 2021 | $2.65 M(+101.4%) | $2.65 M(+62.6%) |
| Sep 2021 | - | $1.63 M(-24.5%) |
| Jun 2021 | - | $2.16 M(-53.4%) |
| Mar 2021 | - | $4.63 M(+251.9%) |
| Dec 2020 | $1.32 M | $1.32 M |
FAQ
- What is Chemomab Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual current liabilities year-on-year change?
- What is Chemomab Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly current liabilities year-on-year change?
What is Chemomab Therapeutics annual total current liabilities?
The current annual current liabilities of CMMB is $4.84 M
What is the all time high annual current liabilities for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual total current liabilities is $6.75 M
What is Chemomab Therapeutics annual current liabilities year-on-year change?
Over the past year, CMMB annual total current liabilities has changed by -$1.91 M (-28.32%)
What is Chemomab Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CMMB is $4.35 M
What is the all time high quarterly current liabilities for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly total current liabilities is $7.00 M
What is Chemomab Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CMMB quarterly total current liabilities has changed by +$41.00 K (+0.95%)